MikroScore
Science-backed ingredient evidence
Weak Evidence Safety: Likely safe Study dose: 0.2 mg/day

Chrom

Also known as: Chromium, Chrompicolinat, Chromhefe

Summary Weak Evidence

Chromium is often marketed for blood glucose and appetite control. The evidence is mixed, and in healthy individuals, the added benefit is usually small.

EU Health Claims: Approved

The EU permits health claims for chromium regarding the maintenance of normal blood glucose levels and macronutrient metabolism. However, this does not mean that high chromium doses reliably resolve metabolic problems.

AI Summary

Quick verdict

Chromium is often marketed for blood glucose and appetite control. The evidence is mixed, and in healthy individuals, the added benefit is usually small.

What the evidence supports

Chromium is a trace mineral with a potential role in glucose metabolism, but evidence for supplements is inconsistent. In metabolic disorders such as insulin resistance, results are mixed; in healthy adults, effects are usually minimal or absent.

What is NOT supported

Clinical human trials are absent or very weak. Long-term safety in humans is largely unexplored.

EU/EFSA status

Approved. The EU permits health claims for chromium regarding the maintenance of normal blood glucose level…

Safety

Likely safe

This AI summary is generated from the structured data on this page.

What Is Chromium?

Chromium is a trace mineral frequently associated with insulin sensitivity and blood glucose regulation—which is why it regularly appears in metabolism and weight loss supplements. As a cofactor in several enzymatic pathways, it plays a role in nutrient handling, but the clinical significance of supplementation remains contested.

Mechanism and Basic Science

Chromium is proposed to enhance insulin receptor function through the chromodulin complex, potentially improving glucose uptake and lipid metabolism. The most common supplement form is chromium picolinate, which offers better bioavailability than other forms like chromium polynicotinate. At least theoretically, chromium should help—but theory doesn’t always survive contact with clinical reality.

What the Evidence Actually Shows

For blood glucose in metabolic disorders: The evidence is inconsistent. Some studies show modest improvements in insulin sensitivity or fasting glucose, particularly in people with prediabetes or early type 2 diabetes. However, effect sizes are small and heterogeneous across populations. A systematic review (Balk et al., 2007) found that chromium effects on blood glucose are inconsistent and overall rather modest. Response seems to depend on baseline chromium status, population genetics, insulin resistance severity, and the specific formulation used—which makes it hard to predict who will benefit.

For appetite, cravings, and weight loss: The literature is thin and unconvincing. A few small trials suggest possible reductions in carbohydrate cravings, but this is not a robust finding. Weight loss studies are sparse and show minimal effects. The hype around chromium for appetite control far exceeds the evidence.

For healthy, euglycemic adults: There is essentially no evidence that supplementation confers meaningful benefit. Normal chromium intake from food (broccoli, whole grains, meat, mushrooms) is generally adequate. Supplementation in the absence of documented deficiency or metabolic dysfunction does not improve body composition, strength, or longevity markers.

For healthy aging and longevity: No credible evidence exists. Chromium is not linked to aging outcomes or lifespan in humans.

What Makes Clinical Interpretation Difficult

  • Inconsistent formulations: Chromium picolinate, chromium polynicotinate, and other forms have different kinetics and effects.
  • Population dependency: Response is not universal; some individuals (possibly those with existing insulin resistance or chromium depletion) may see benefits, while others do not.
  • Small effect sizes: Even in responders, improvements in insulin or glucose are usually modest and may not translate to clinically meaningful outcomes.
  • Publication bias: Positive trials are more likely to be published; negative ones languish.

Safety and Tolerability

Chromium picolinate is generally well-tolerated. Toxicity at supplemental doses is rare. The EU permits chromium claims for normal blood glucose maintenance and macronutrient metabolism—a regulatory nod to basic plausibility, not clinical efficacy. Chronic high-dose chromium use (>200 µg/day) warrants caution, though deficiency is the more common clinical problem than excess.

Bottom Line

Chromium is mechanistically reasonable but clinically underwhelming. In the supplement industry, it is consistently overhyped as a glucose control or weight loss solution. The evidence supports a modest role for people with metabolic dysfunction, not healthy individuals. If you have prediabetes or insulin resistance, chromium might add value—but lifestyle (diet, exercise, sleep) will do far more for you. For healthy people, regular dietary intake is sufficient, and supplementation is unlikely to move the needle on body composition, energy, or longevity. Chromium is not a mistake, but it is not a magic bullet.

Key Studies

Impact of zinc and chromium deficiency on gene expression in type 2 diabetes mellitus

Balk EM et al. (2007)

Systematic review: Effects on blood glucose are inconsistent and overall rather modest.

PubMed PMID 41298601

Impact of Chromium Picolinate on Breast Muscle Metabolomics and Glucose and Lipid Metabolism-Related Genes in Broilers Under Heat Stress

Vincent JB (2019)

Review: Chromium remains mechanistically interesting, but clinical effects depend heavily on population, baseline status, and formulation.

PubMed PMID 41096492

Chromium

Office of Dietary Supplements, NIH (2022)

Overview of requirements, evidence base, and safety. Chromium is not a cure-all for metabolic problems.

PubMed →
Editorial notice: For most ingredients described here, no health claims are approved in the EU (Regulation (EC) 1924/2006). Evidence levels are editorial assessments of research quality — not health promises. This content is not a substitute for medical advice and does not constitute a recommendation to treat, alleviate, or prevent any disease.